Vivos (RDGL) Total Debt (2011 - 2023)

Vivos' (RDGL) quarterly Total Debt came in at $10000.0 in Q3 2023, down 99.97% quarter-over-quarter from $30.1 million in Q3 2018.

Vivos (RDGL) Total Debt (2011 - 2023) Analysis & Trends

Vivos has disclosed Total Debt across 9 years of filings, most recently posting $10000.0 for Q3 2023.

Total Debt for Q3 2023 came in at $10000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2023 was $10000.0 (changed N/A YoY), and the FY2016 annual result was $452065.0, down 89.61% from the prior year.
Total Debt came in at $10000.0 for Q3 2023 at Vivos, down from $30.1 million in the prior quarter.
In the past five years, Total Debt ranged from a high of $10000.0 in Q3 2023 to a low of $10000.0 in Q3 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	34.05 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.72 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.48 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.93 Bn
10	Vivos	-	-	-3,105.00	-

Historic Data

Download Data

Date	Value
Sep 30, 2023	10,000.00
Sep 30, 2018	30.06 Mn
Jun 30, 2018	5.23 Mn
Mar 31, 2018	40,000.00
Sep 30, 2017	383,771.00
Jun 30, 2017	383,771.00
Mar 31, 2017	383,771.00
Dec 31, 2016	452,065.00
Sep 30, 2016	332,195.00
Jun 30, 2016	1.59 Mn
Mar 31, 2016	1.33 Mn
Dec 31, 2015	4.35 Mn
Sep 30, 2015	2.72 Mn
Jun 30, 2015	195,500.00
Mar 31, 2015	9.19 Mn
Dec 31, 2014	4.43 Mn
Sep 30, 2014	512,094.00
Jun 30, 2014	2.13 Mn
Mar 31, 2014	485,402.00
Dec 31, 2013	349,913.00